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Fibrous hamartoma of infancy (FHI) is a rare, benign lesion characterized as a tumor of myofibroblastic origin
that has characteristic features of triphasic histology. FHI was first described in 1956 by Reye and formally
named by Enzinger in 1965 [1-2]. The lesion is defined as a hamartoma due to the histologic presentation of
disorganized mesenchymal, fibrous, and adipose tissue with absence of mitotic figures; this combination of
derived tissue without evidence of anaplasia is diagnostic for FHI. These lesions typically arise as a single, sol
itary mass, are most commonly located on the extremities, trunk, sacrum, or scrotum and are typically 0.5 to 9.0
centimeters in size [3-4]. Only roughly 200 cases have been reported in the literature [3]. The majority of cases
occur in young children; 91% of cases arise within the first year of life [4]. Males are more often affected in a
ratio of 2.4:1 [4]. Roughly 20% of cases have been documented as congenital (3). Treatment is surgical excision,
which is often curative; local recurrence is rare and incidence decreased by obtaining negative margins (8). We
present a case of congenital FHI identified at birth.

1. Case report
Patient is a female infant born to an experienced mother via repeat Csection. There was no significant family past medical history including
no history of childhood tumors or genetic syndromes. Newborn course
was complicated by neonatal hyperbilirubinemia which resolved after
phototherapy. She received hepatitis B vaccine and vitamin K in left
thigh. On initial assessment, prior to vaccination, she was noted to have
a non-tender anterior left thigh mass without overlying skin changes
with an otherwise benign exam. On subsequent exams, the thigh mass
was noted to be more localized and firm and it did not appear to cause
any distress to the patient. She was neurovascularly intact distal to the
lesion and she moved all extremities spontaneously and equally. Due to
low concern for immediate intervention of the mass, the patient was
discharged with routine newborn follow up. Newborn state screen
returned negative.
During a visit on day of life 11, the provider noted that the mass
appeared more condensed and was firm to touch. Concern arose about
the origin of the mass from a skeletal vs. muscular vs. adipose origin. Left
femur x-ray was obtained and radiology report demonstrated no bony
involvement and the mass most likely originates from soft tissue. Left
lower extremity ultrasound was obtained to evaluate the mass in more

detail (Fig. 1-A, 1-B). The mass was found to be muscular in origin but
etiology remained unclear. Referral to pediatric surgery was made for
evaluation of the left soft tissue lesion.
Pediatric surgery evaluated the patient on day of life 14. The pro
vider identified the left anterior thigh mass on exam, which measured 3
cm in diameter, and palpated the lesion intramuscularly. The patient
was noted to be neurovascularly intact with full painless range of motion
and there was no evidence of overlying skin changes. Pediatric surgery
recommended left thigh MRI to better evaluate the mass. MRI was ob
tained of the left thigh which demonstrated a heterogenous mass with
internal fat and moderate heterogeneous internal enhancement with
marked peripheral enhancement distally within the rectus femoris
muscle belly (see Fig. 2-A, 2-B). Pediatric hematology/oncology referral
was obtained due to potential of neoplastic lesion. Pediatric surgery and
pediatric hematology/oncology both recommended tissue biopsy for
histopathologic evaluation of the lesion.
Biopsies were obtained from the overlying skin, medial, anterior, and
lateral aspects of the lesion. She was discharged after short admission for
the procedure. Biopsy results were confirmed 1 month after specimens
were obtained. Surgical pathology report indicated the lesion to be low
grade, benign appearing myofibroblastic and fibroblastic neoplasm.
Immunostains were performed which showed positive staining for SMA
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and negative for desmin, CD34, S-100, and SOX10 (see Fig. 3-A, 3-B, 3-C,
3-D). Some cases have extensive pseudoangiomatous morphology with
accompanying CD34-positivity which may raise the differential diag
nosis of giant-cell fibroblastoma and dermatofibrosarcoma protuberans.
These features were not present in this case. The differential diagnosis in
this case was chiefly limited to lipofibromatosis, lipofibromatosis-like
neural tumor and other TRK-associated tumors, and infantile fibrosar
coma. An anchored multiplex PCR based NGS gene fusion assay covering
the NTRK genes was performed and was negative, excluding, in
conjunction with the morphology, infantile fibrosarcoma,
lipofibromatosis-like neural tumor, and the remaining TRK-associated
tumors. The triphasic morphology, more slender spindle cells, and
lack of myxoid stroma favor fibrous hamartoma of infancy over
lipofibromatosis.
Plan of care for this patient includes routine monitoring of the
unresected mass at well child checks with primary pediatrician as well as
surveillance by pediatric oncology prior to 1 year of life. Discussions for
resection continue with initial plan to resect when she grows larger
unless complications such as musculoskeletal, neurovascular, or onco
logic complications arise.

documented FHI lesions with rapid growth and those associated with
overlying warmth, pain, and/or tenderness as well as hyperpigmenta
tion, hypertrichosis, and hyperhidrosis [7–9]. These lesions are largely
benign and are inherently defined by the absence of mitotic figures and
anaplasia.
It can be difficult to accurately diagnose FHI as the differential
diagnosis is wide for a soft tissue lesion. Differential diagnosis includes
hemangioma, myofibroma, fibrous hamartoma, infantile fibrosarcoma,
infantile
myofibromatosis,
rhabdomyosarcoma,
and
nonrhabdomyosarcoma soft tissue tumors.
Initial workup of a soft tissue lesion typically begins with radiologic
evaluation to distinguish location of lesion as well as estimated size and
preliminary composition assessment. In a review by Ji et al., x-ray has
little diagnostic value as lesions do not have characteristic appearance,
however cross-sectional imaging modalities such as CT and MR can be
useful in determining histological origins and ruling out challenging
differential diagnoses [10]. On CT and MR imaging, lesions consistent
with FHI present as soft tissue mass with oval shape (balanced type) or
irregular shape (non-balanced type) [10]. The latter, non-balanced type,
has a greater tendency to invade deep fascia and can make surgical
resection with negative margins more challenging. Ji et al. suggests that
MR imaging is useful diagnostically due to the ability to differentiate
between tissue types; fat-containing FHI lesions demonstrate adipose
signal intensity, ruling out dominantly low signal fibrous tissue tumors
including infantile fibromatosis, myofibromatosis, and congenital fi
brosarcomas [10]. Other adipose-containing tumors may be more
difficult to distinguish. There is no role for ultrasound in the diagnosis of
FHI.
Histopathologic features and immunostaining techniques aid in
diagnosis to differentiate FHI from other cancerous lesions and rich

2. Discussion
Fibrous hamartoma of infancy commonly presents as a slow-growing
and asymptomatic subcutaneous mass classically located in the axilla,
abdomen, extremities, or genitalia however approximately half of cases
present at unusual sites, as in this case [5]. Most tumors are freely mo
bile, nontender, and well circumscribed; it is rare that lesions are
encapsulated and some may exclude the diagnosis of FHI if encapsula
tion is present on histologic assessment [6]. However, case reports have

Fig. 1. (A–B) demonstrates ultrasound findings of the thigh mass on day of life 11. Fig. 1-A is the transverse view and Fig. 1-B, the longitudinal view. Ultrasound
demonstrates the heterogenous nature of the mass with presumptive origin from the musculature however unable to be confirmed without more detailed imaging.
2

E.A. Waldrop et al.

Journal of Pediatric Surgery Case Reports 70 (2021) 101894

Fig. 2. (A–B) demonstrates MRI findings of the left anterior thigh and the mass
in question. MRI demonstrates a heterogenous mass with internal fat and
moderate heterogeneous internal enhancement with marked peripheral
enhancement distally within the rectus femoris muscle belly.

adipose tumors. A careful histopathologic examination meeting criteria
is diagnostic. The characteristic microscopic histologic features of FHI
include triphasic hamartomatous components: (i) primitive undifferen
tiated spindle cells and mesenchymal tissue organized in whorls, bands,
or nests, (ii) well-defined fibroblastic to myofibroblastic bundles and
(iii) intimate admixture of mature adipose tissue [11]. The proportion of
these elements are variable in reported cases but all contained this
classical triphasic morphology [5]. Immunostaining can support diag
nosis but is not specific for FHI. In the large clinicopathologic study by
Al-Ibraheemi, immunostaining was positive in all cases for S100 protein,
expressed by adipocytes, and CD34, expressed by primitive mesenchyme
[5]. Immunostaining for desmin was negative in all tested cases [5].
Presence of smooth muscle action (SMA) expressed by myofibroblasts is
also consistent with a diagnosis of FHI [12]. FISH analysis on biopsied
material can aid in ruling out particular diagnoses if histologic exami
nation is inconclusive; absence of PDGFB (positive in giant cell fibro
blastoma), absence of ETV6 (positive in infantile fibrosarcoma), and

Fig. 3. Showing the classic histologic features of fibrous hamartoma of infancy.
The spindle cells show an intimate relationship with mature adipose tissue
(A–C) and vary from primitive (B and D) to fibroblastic (C). Cytologically, the
cells are variably plump and bland without cytologic atypia.

absence of NTRK (positive in soft tissue sarcomas) is support diagnosis of
FHI. In our case, histopathologic examination of biopsied material
demonstrated positive classical triphasic morphology, immunopositivity
for SMA, and absence of ETV6 and NTRK on FISH analysis, suggestive of
a diagnosis of FHI.
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Patient consent

The treatment of choice is local excision, unless excision will be
mutilating or result in significant poor cosmetic outcome. Current sur
gical recommendation includes obtaining 1.0 cm surgical margin; the
majority of cases with local recurrence occurred in those that did not or
were not able to obtain adequate negative margin [3,13]. In cases which
resection is difficult or incompletely performed, tyrosine kinase in
hibitors may be used as adjunct therapy [14]. In the large case review by
Al-Ibraheemi of 145 cases, follow up information was available for 52
patients; local recurrences after resection were seen in 2 patients, or 1%,
and no cases of metastasis were documented [5]. With low risk of spread
without surgical removal, low risk of local recurrence, and no docu
mentation of metastasis in the literature, the diagnosis of FHI carries an
excellent prognosis.

Consent to publish the case report was not obtained. This report does
not contain any personal information that could lead to the identifica
tion of the patient.
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